Skip to Content
Home > About Us > Research and Grants Administration > Detail
<< Back to Results
The purpose of this study is to compare getting more treatment with capecitabine (i.e. one of the usual approaches), to any good and bad effects of getting more treatment with a platinum-based chemotherapy (cisplatin or carboplatin), after surgery for patients with triple-negative breast cancer.
Patients that are eligible for this study include:
View Additional Section Content
For more information about our research program and IRB, please contact: